Cancer Therapy News and Research

RSS

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

A new study finds many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals, and says investigators should be committed not just to finding novel compounds, but also to make sure final results of their studies be disseminated to the medical community.

22 Aug 2005

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.

15 Aug 2005

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

Researchers have discovered that tumors release fatty acids that interfere with the cells that are trying to kill them. Consequently, strategies that reduce the amount of fatty acids surrounding the tumors may give a boost to anti-cancer therapeutics.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Breast cancer patients could find out whether they will respond positively to chemotherapy treatment by testing for the activity of certain genes.

9 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Monash University software helps tackle cancer and aircraft design

A powerful software tool designed by academics at Monash University is being used in the UK to help develop cancer treatments and improve aircraft engine design.

2 Aug 2005

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

An analysis of more than 100 studies of cancer survivors shows that many survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis, but that those who are male, older, and less educated are less likely to adopt such changes. The term "cancer survivor" refers to a person who has been diagnosed with cancer.

25 Jul 2005

Government in Ontario will pay for three new cancer drugs

Canadian Health Minister George Smitherman has announced that the government will add three new and expensive cancer-fighting drugs to the list of medications it funds.

25 Jul 2005

Potential new target for stomach cancer therapy

It started several years ago with the observation that a large group of seemingly unconnected genes were behaving differently in patients with stomach cancer.

24 Jul 2005

Many testicular cancer patients are able to father children

According to Dr Robert Huddart of the Institute of Cancer Research in London, the vast majority of men, after testicular cancer treatment, can go on and have a family as normal.

23 Jul 2005

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

21 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Fertility boost for testicular cancer patients

The vast majority of men who try to have a family, following treatment for testicular cancer, are able to father children - according to a report published today in the British Journal of Cancer.

21 Jul 2005

No single PSA level ensures safety from prostate cancer risk

Ian M. Thompson Jr., M.D., professor and chair of urology at the U T Health Science Center, is looking for a better test - or set of tests - to diagnose prostate cancer and to distinguish between cancers that will kill men if left untreated and those that will not threaten health and do not need treatment.

19 Jul 2005

Cancer patients are being forced to bear the massive financial burden of changes in NHS treatment

The side effects of cancer treatment mean patients often have to give up work, and may have to live on a low income; forcing many patients to make a choice between finding the money for travel to hospital and basic necessities such as food, children's clothes and household bills.

19 Jul 2005

Innovative new brachytherapy planning tool

The Vitesse system is being used in more than 25 hospitals worldwide to speed up planning and enable treatments to take place within a day, avoiding the need for patients to stay in a hospital overnight.

19 Jul 2005

Fever might be a useful weapon in the fight against cancer

A therapeutic approach for battling cancer that is based on infection with a specially designed virus similar to the one that causes the common cold has shown promise in clinical trials. Now, new research suggests that fever might be a useful weapon in the fight as well.

18 Jul 2005

Compound derived from cottonseed could help improve the effectiveness of chemotherapy at treating head and neck cancer

The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.

18 Jul 2005

Cancer Therapy News and Research

A cell's energy level is critical to its survival

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

FDA approval sought for Pfizer's new cancer drug

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Monash University software helps tackle cancer and aircraft design

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

Government in Ontario will pay for three new cancer drugs

Potential new target for stomach cancer therapy

Many testicular cancer patients are able to father children

Provectus to begin clinical trials of new cancer treatment, PV-10

Role of IL-24 in regulating the immune system

Fertility boost for testicular cancer patients

No single PSA level ensures safety from prostate cancer risk

Cancer patients are being forced to bear the massive financial burden of changes in NHS treatment

Innovative new brachytherapy planning tool

Fever might be a useful weapon in the fight against cancer

Compound derived from cottonseed could help improve the effectiveness of chemotherapy at treating head and neck cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News